Financial News Feed

Weaker Buy Today RETA ranks #1083 as BUY CANDIDATE. Stronger Buy
Today RETA ranks #1083 as BUY CANDIDATE.

RETA stock RETA

RETA stock
RETA

We are comparing Reata Pharmaceuticals Inc. (NASDAQ:RETA) and Zafgen Inc. (NASDAQ:ZFGN) on their profitability, analyst recommendations, risk, dividends, institutional ownership, earnings and valuatio...

Read more

We will be contrasting the differences between Onconova Therapeutics Inc. (NASDAQ:ONTX) and Reata Pharmaceuticals Inc. (NASDAQ:RETA) as far as profitability, analyst recommendations, risk, dividends, ...

Read more

Both Reata Pharmaceuticals Inc. (NASDAQ:RETA) and Syndax Pharmaceuticals Inc. (NASDAQ:SNDX) are Biotechnology companies, competing one another. We will...

Read more

Owens Realty Mortgage Inc (ORM) investors sentiment decreased to 0.57 in Q4 2018. It’s down -0.23, from 0.8 in 2018Q3. The ratio turned negative, as 13 hedge funds increased and opened new stock pos...

Read more

Reata Pharmaceuticals Inc (NASDAQ:RETA) CFO Jason Douglas Wilson sold 5,604 shares of the company’s stock in a transaction on Monday, March 18th. The shares were sold at an average price of $94.04, ...

Read more

Both Reata Pharmaceuticals Inc. (NASDAQ:RETA) and Minerva Neurosciences Inc. (NASDAQ:NERV) are each other’s competitor in the Biotechnology industry. Thus the...

Read more

Reata Pharmaceuticals Inc (NASDAQ:RETA) CFO Jason Douglas Wilson sold 4,000 shares of the firm’s stock in a transaction dated Friday, March 15th. The shares were sold at an average price of $93.62, ...

Read more

Since Oncolytics Biotech Inc. (NASDAQ:ONCY) and Reata Pharmaceuticals Inc. (NASDAQ:RETA) are part of the Biotechnology industry, they are influenced by...

Read more

Traders following current indicator levels on shares of Reata Pharma Cla (RETA) can note that the short-term MACD indicator is presently reading a Buy. The MACD is typically used to measure bullish or...

Read more

iShares Trust – iShares Europe ETF (ARCA:IEV) boasts a Price to Book ratio of 0.877224. This ratio is calculated by dividing the current share price by the book value per share. Investors may use Pr...

Read more

Neurotrope Inc. (NASDAQ:NTRP) and Reata Pharmaceuticals Inc. (NASDAQ:RETA) compete against each other in the Biotechnology sector. We will compare them and...

Read more

We will be comparing the differences between Mersana Therapeutics Inc. (NASDAQ:MRSN) and Reata Pharmaceuticals Inc. (NASDAQ:RETA) as far as dividends, analyst...

Read more

As Biotechnology companies, DiaMedica Therapeutics Inc. (NASDAQ:DMAC) and Reata Pharmaceuticals Inc. (NASDAQ:RETA) are our subject to contrast. And more...

Read more

Reata Pharmaceuticals, Inc. (NasdaqGM:RETA) has a Piotroski F-Score of 2 at the time of writing. The F-Score may help discover companies with strengthening balance sheets. The score may also be used t...

Read more

Howard Financial Services LTD. purchased a new position in Reata Pharmaceuticals Inc (NASDAQ:RETA) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund pur...

Read more

News Feed powered by

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank